PROCOS is a contract manufacturer based in Italy. It holds 20 active US drug master files and 2 valid CEPs across a filed portfolio of 22 molecules. Its most recent recorded inspection, by US FDA, closed on 16 September 2022 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Italy, Italy | 3002807938 |
| Cameri, Italy | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Pyridostigmine | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Memantine | SFDA (Saudi Arabia), US FDA | 2 |
| Orphenadrine | SFDA (Saudi Arabia), US FDA | 2 |
| Pirfenidone | EDQM, US FDA | 2 |
| Alverine | SFDA (Saudi Arabia) | 1 |
| Candesartan Cilexetil | SFDA (Saudi Arabia) | 1 |
| Carglumic Acid | US FDA | 1 |
| Clofedanol | US FDA | 1 |
| Dalfampridine | US FDA | 1 |
| Efinaconazole | US FDA | 1 |
| Embutramide | US FDA | 1 |
| Felbamate | US FDA | 1 |
| Guanfacine | US FDA | 1 |
| Iloperidone | US FDA | 1 |
| Istradefylline | US FDA | 1 |
| Labetalol | US FDA | 1 |
| Lofexidine | US FDA | 1 |
| Lurasidone | US FDA | 1 |
| Midostaurin | US FDA | 1 |
| Phenelzine | US FDA | 1 |
| Propafenone | US FDA | 1 |
| Trospium | US FDA | 1 |
Also appears on these molecule pages
Choose your molecules and target markets. PROCOS comes back tiered against every other supplier able to file there.
Start for free